HZNP - Horizon Therapeutics ticks higher amid speculation of activist investor

• Horizon Therapeutics ( NASDAQ: HZNP ) ticked up 0.3%, quickly paring an earlier decline, on speculation that the company may be the target of an activist after a 13-F filing.
• Barclays added 3.56 million shares in 3Q, up from 288K in the prior quarter, Dealreporter and Gordon Haskett highlighted in items this morning. It's possible that an activist investor may be accumulating the shares through Barclays.
• Gordon Haskett pointed out that the nomination window for directors at Horizon Therapeutics ( HZNP ) opened on Oct. 18 and is set to. Dec. 17.
• The additions from Barclays is noteworthy because prime brokerage sometimes acts as counterparties for activist swap positions.
• Horizon Therapeutics jumped 11% on Wednesday after strong sales for arthritis therapy prompted a guidance raise.
• Recall August, BioMarin may be an activist target after 13-F filings.

For further details see: